logo
Share SHARE
FONT-SIZE Plus   Neg

Libbey Turns To Profit In Q1

Libbey Inc. (LBY) reported first-quarter net income of $0.6 million or $0.03 per share, compared to a net loss of $1.0 million or $0.05 per share last year.

Net sales for the quarter rose to $187.8 million from $181.0 million a year ago.

The company also announced that its subsidiary, Libbey Glass Inc., plans to call for redemption of an aggregate principal amount of $40.0 million of its outstanding 10.0 percent senior secured notes due 2015 prior to the second quarter.

The company plans to fund this redemption using cash on its balance sheet and/or borrowings under its Asset Backed Loan credit facility. This redemption is expected to result in a one-time charge of $2.2 million or about $0.10 per share in the second quarter for early extinguishment of debt.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Credit Suisse Group AG gained around 8 percent in the morning trading in Zurich after the Swiss banking giant raised its group cost savings target, and also confirmed its medium-term 2018 pre-tax income target. It is almost the end of the year. With the exception of a few, many of the biotech stocks, like the following, on which investors had bet big this year have served up only heartbreak. Now, let's take a look at some of the pending clinical trial catalysts of this month, which will make it a December to remember. Fast food major McDonald's is investing in $12,000 espresso machines for all of its U.S. restaurants, with a view to challenge Starbucks and Dunkin' Donuts in the coffee business, Bloomberg reported. Aiming to attract more customers, the company plans to reintroduce its coffee shop McCafe in 2017..
comments powered by Disqus
Follow RTT